title: Recombinant human erythropoietin alpha in the correction of anaemia in epidermolysis bullosa.
authors.forename: I
authors.initials: I
authors.lastname: Antunes
authors.forename: C
authors.initials: C
authors.lastname: Resende
authors.forename: E
authors.initials: E
authors.lastname: Granjo
authors.forename: J
authors.initials: J
authors.lastname: Mesquita-Guimãres
mesh_terms: D000328:Adult; D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D001803:Blood Transfusion; D002908:Chronic Disease; D003692:Delayed-Action Preparations; D016108:Epidermolysis Bullosa Dystrophica / Q000150:complications*; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D005296:Ferrous Compounds / Q000627:therapeutic use; D005492:Folic Acid / Q000627:therapeutic use; D006397:Hematinics / Q000627:therapeutic use; D006801:Humans; D011994:Recombinant Proteins
chemical_list: D003692:Delayed-Action Preparations; D005296:Ferrous Compounds; D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; C020748:ferrous sulfate; D005492:Folic Acid